Phil Nadu
Analyst, TD Cowen
Replay available
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2025 Earnings Call
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2025 earnings conference call, held 2026-02-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Corey Kasnov
Analyst, Evercore ISI
Michael Yee
Analyst, UBS
Brian Abrams
Analyst, RBC Capital Markets
William Pickering
Analyst, Bernstein
Evan Siegerman
Analyst, BMO Capital Markets
Suzy Lisa
Senior Vice President, Investor Relations
Salveen Richter
Analyst, Goldman Sachs
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Vertex Pharmaceuticals Incorporated.
Replay transcript excerpt
WEBVTT 00:00:01.347 -- 00:00:07.276 Good day and welcome to the Vertex Pharmaceuticals fourth quarter 2025 earnings call. 00:00:07.276 -- 00:00:09.720 All participants will be in a listen-only mode. 00:00:09.720 -- 00:00:13.225 Should you need assistance, please signal conference specialists by pressing the star 00:00:13.225 -- 00:00:17.772 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:17.772 -- 00:00:21.257 questions. Please note this event is being recorded. 00:00:21.257 -- 00:00:23.220 I would now like to turn the conference over to Ms. 00:00:23.220 -- 00:00:26.187 Susie Lisa. Please go ahead. 00:00:26.187 -- 00:00:30.152 Good evening, everyone. My name is Suzy Lisa, and as Senior Vice President of Investor 00:00:30.152 -- 00:00:34.879 Relations, I'd like to welcome you to our fourth quarter and full year 2025 Financial 00:00:34.879 -- 00:00:39.225 Results Conference Call. On tonight's call, Making Prepared Remarks, we have Dr. 00:00:39.225 -- 00:00:44.292 Reshma Kewalramani, Vertex's CEO and President, Charlie Wagner, Chief Operating Officer 00:00:44.292 -- 00:00:48.317 and Chief Financial Officer, and Duncan McKechnie, Chief Commercial Officer. 00:00:48.317 -- 00:00:51.962 We recommend that you access the webcast slides as you listen to this call. 00:00:51.962 -- 00:00:55.347 The call is being recorded, and a replay will be available on our website. 00:00:55.347 -- 00:00:59.431 We will make forward-looking statements on this call that are subject to the risks and 00:00:59.431 -- 00:01:03.816 uncertainties discussed in detail in today's press release and in our filings with the 00:01:03.816 -- 00:01:08.141 Securities and Exchange Commission. These statements, including without limitation those 00:01:08.141 -- 00:01:13...